TABLE 2.
Day (day 1 is first day with symptoms) | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meropenem dosage | 2 g × 3 | → | → | → | 2 g × 4 | → | → | → | → | → | 3 g bolus +12 g/day b | 12 g/day b | 16 g/day b | → | → | 12 g/day b | → | → | |
Meropenem trough concentration (mg/L) (> 8 mg/L) a | 1.3 | 11 | 23 | 31 | 17 | ||||||||||||||
Acyclovir | 800 mg × 3 | → | → | → | |||||||||||||||
Betamethasone | 8 mg × 4 | → | → | → | |||||||||||||||
Cefotaxime | 3 g × 4 | ||||||||||||||||||
Metronidazole | 1.5 g | 0.5 g × 3 | → | → | → | → | → | → | → | → | → | → | → | → | → | ||||
Vancomycin dosage | 2 g bolus + 1.5 g ×3 | 1.5 g × 3 | 2 g × 3 | → | 2 g × 4 | 2 g × 3 | 1.5 g × 4 | → | → | → | → | → | → | → | |||||
Vancomycin trough concentration (mg/L) (15–20 mg) a | 6.5 | 9.8 | 9.0 | 22.3 | 11.7 | 14.6/12.6 | 12.0 | 15.1 | 19.6 | 18.7 | 19.3 | ||||||||
Trimethoprim–sulfamethoxazole (TMP-SMX) (16 mg/ml, 80 mg/ml) | 40 ml × 2 | ||||||||||||||||||
Trimethoprim trough concentration (mg/L) | 2.8 | ||||||||||||||||||
Sulfamethoxazole trough concentration (mg/L) | 75.8 | ||||||||||||||||||
Rifampicin | 450 mg × 2 | → | 600 mg × 2 | → | |||||||||||||||
Vancomycin intrathecal dosage (mg single dosage) | 10 | 10 | 10 | 10 | 20 | 20 | 20 | 20 | |||||||||||
Vancomycin intrathecal (CSF) trough concentration (mg/L) | <4 | <4 | <4 | <4 | <4 | 11.9 | <4 | 12.4 | <4 |
Reference values.
Continuous infusion.